(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NICTUR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NICTUR

ST13

US500000079228430

Class

5

Filing

79228430

Registration

5663531

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

04/16/2026

Trademark type

Word

Nice classes

5

Filing date

11/10/2017

Registration date

01/29/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/15/2025

Last transaction

04/16/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

85

Owner location

SantQuinti de Mediona (Barcelona), ES

Examiner

DAWE III, WILLIAM H

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

GP PHARM, S.A.

Representatives

Elizabeth Lee Lucas & Mercanti, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for human use for treating nighttime or daytime enuresisprimary nocturnal enuresisnocturiaVon Willebrand-Jurgens diseasehemorrhagingbleeding in patients with Hemophilia Apostoperative bleeding and diabetes insipidusfor the management of surgical hemostasisfor use in renal concentrating capacity testfor use in oncologyfor treating cancerfor treating cardiovascular diseasesfor use as antiviralsfor treating inflammatory diseases and disorders of the intestinefor treating inflammatory diseases and disorders of the connective tissuefor treating arthritisfor treating urological diseases and disordersfor treating hormonal diseases and disordersfor treating endocrinological diseases and disordersfor treating psychiatric diseases and disordersin particular mood disordersanxiety disorderscognitive disorders and schizophreniafor treating neurological and neurodegenerative diseases and disordersin particulardementia linked to Alzheimer's diseaseHuntington's diseaseParkinson's diseasecerebral palsybrain injuries and diseasesinjuries and diseases of the spinal cordconvulsive disordersepilepsyencephalitisdisorders of the central nervous systemocular motility disordersdystoniablepharospasmstrabismusfacial scoliosis and ticscerebral ischemiadementiaamyotrophic sclerosislateral multiple sclerosisfor treating auto-immune diseases and disordersfor treating transplant rejectionfor treating ophthalmological diseases and disorders such as proliferative or non-proliferative diabetic retinopathymacular degenerationage-related macular degenerationretinal neovascularizationneovascularization associated with choroidal melanomaretinopathycentral retinal vein occlusionpigmentary retinitisuveitismacular edema and cystoid macular edema; synthetic peptides for the treatment of urologicalendocrine and blood diseases and disorders

Publications

History of USPTO decisions and trademark events.

30 publications found

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

04/15/2026

C71T

CANCELLED SECTION 71

08/15/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/29/2024

RNWL

INTERNATIONAL REGISTRATION RENEWED

10/19/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/07/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/22/2019

FIMP

FINAL DISPOSITION PROCESSED

05/21/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/29/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/25/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/25/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

01/29/2019

GPNX

NOTIFICATION PROCESSED BY IB

11/23/2018

PUBO

PUBLISHED FOR OPPOSITION

11/13/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/24/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/24/2018

NPUB

NOTICE OF PUBLICATION

10/24/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/24/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/20/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/19/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/19/2018

RFNT

REFUSAL PROCESSED BY IB

04/13/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/20/2018

RFRR

REFUSAL PROCESSED BY MPU

03/20/2018

MAFR

APPLICATION FILING RECEIPT MAILED

03/16/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/14/2018

CNRT

NON-FINAL ACTION WRITTEN

03/13/2018

DOCK

ASSIGNED TO EXAMINER

03/12/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/12/2018

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

03/09/2018

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

03/08/2018

Continuous trademark protection

Get notified about every new filing that threatens NICTUR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.